Stabilized humicola lanuginosa lipase variants in water-soluble films
US-10457920-B2 · Oct 29, 2019 · US
US11268076B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11268076-B2 |
| Application number | US-201515526834-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 8, 2015 |
| Priority date | Dec 9, 2014 |
| Publication date | Mar 8, 2022 |
| Grant date | Mar 8, 2022 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a variant of a parent lipase, which parent lipase has the amino acid sequence of SEQ ID NO: 2, wherein the variant has lipase activity, comprises a substitution at a position corresponding to position 51 and comprises a substitution or remains unaltered at a position corresponding to position 96 of SEQ ID NO: 2. The present invention also relates to polynucleotides encoding the variants; nucleic acid constructs, vectors, and host cells comprising the polynucleotides; and methods of using the variants.
Opening claim text (preview).
The invention claimed is: 1. A lipase variant which (a) comprises a V at a position corresponding to position 51 of SEQ ID NO: 2 and comprises a substitution or is unaltered at a position corresponding to position 96 of SEQ ID NO: 2, (b) has at least 97% but less than 100% sequence identity to SEQ ID NO: 2, (c) has improved stability as compared to the polypeptide of SEQ ID NO: 2, and (d) has lipase activity. 2. The lipase variant of claim 1 , which is unaltered at a position corresponding to position 96 of SEQ ID NO: 2. 3. The lipase variant of claim 1 , which comprises a substitution at a position corresponding to position 96 of SEQ ID NO: 2. 4. The lipase variant of claim 3 , wherein the substitution at a position corresponding to position 96 of SEQ ID NO: 2 is with Asp, Leu, or Trp. 5. The lipase variant of claim 1 , further comprising one or more amino acid substitutions corresponding to the following substitutions of SEQ ID NO: 2, selected from the group consisting of: V2F/G/H/K/R/Y; N33H/K/R/P/Q; S54T; E56H/K/R; D57G/N; T64S; L69H/K/R; K98E/D/I/R/T/V; E87E/F/H/I/K/M/Q/R; N101D/E; K163G/P; V176L; E210H/K/R; Y220F; A243P/S/T; W260F/Y; and L269I/V. 6. The lipase variant of claim 2 , further comprising one or more amino acid substitutions corresponding to the following substitutions of SEQ ID NO: 2, selected from the group consisting of: V2F/G/H/K/R/Y; N33H/K/R/P/Q; S54T; E56H/K/R; D57G/N; T64S; L69H/K/R; K98E/D/I/R/T/V; E87E/F/H/I/K/M/Q/R; N101D/E; K163G/P; V176L; E210H/K/R; Y220F; A243P/S/T; W260F/Y; and L269I/V. 7. The lipase variant of claim 4 , further comprising one or more amino acid substitutions corresponding to the following substitutions of SEQ ID NO: 2, selected from the group consisting of: V2F/G/H/K/R/Y; N33H/K/R/P/Q; S54T; E56H/K/R; D57G/N; T64S; L69H/K/R; K98E/D/I/R/T/V; E87E/F/H/I/K/M/Q/R; N101D/E; K163G/P; V176L; E210H/K/R; Y220F; A243P/S/T; W260F/Y; and L269I/V. 8. The lipase variant of claim 1 , comprising a set of amino acid substitutions corresponding to the following substitutions of SEQ ID NO: 2, selected from the group consisting of: a. V2K+N33K+F51V+S54T+L69R+K98E+V176L+E210K+W260Y; b. V2K+N33K+F51V+L69R+K98E+V176L+V187P+E210K+L227G; c. V2K+N33K+F51V+L69R+K98E+V176L+E210K+S224F+L227G; d. V2K+N33K+F51V+L69R+K98E+V176L+E210K+L227G; e. V2K+N33K+F51V+L69R+K98E+V176L+E210K+L227G+V228P; f. V2K+N33K+F51V+L69R+K98E+E210K+L227G; g. V2K+N33K+F51V+V187P; h. V2K+N33K+F51V+S224F; i. V2K+N33K+F51V+L227D; j. V2K+N33K+F51V+V228P; k. V2K+F51V; I. V2Y+N33K+F51V; m. V2Y+N33K+F51V+E56K+L69R+E96D+K98E; and n. V2Y+N33K+F51V+E56K+L69R+K98E. 9. The lipase variant of claim 1 , comprising a set of amino acid substitutions corresponding to the following substitutions of SEQ ID NO: 2, selected from the group consisting of: a. N33K+F51V; b. N33K+F51V+S54T+E56K+L69R+K98E+W260Y; c. N33K+F51V+S54T+E56K+K98E+E210K+W260Y; d. N33K+F51V+S54T+E56K+K98I; e. N33K+F51V+S54T+E56K+K98I+T143A; f. N33K+F51V+S54T+L69R+E87K+K98E+E210K+Y220F; g. N33K+F51V+S54T+K98E+W260Y; h. N33K+F51V+S54T+K98I; i. N33K+F51V+E56K+L69R+E96D+K98E; j. N33K+F51V+E56K+L69R+E96D+K98E+V187D; k. N33K+F51V+E56K+L69R+E96D+K98E+G225P; l. N33K+F51V+E56K+L69R+K98E; m. N33K+F51V+E56K+L69R+K98E+V176L+E210K+Y220F; n. N33K+F51V+E56K+L69R+K98E+V176L+E210K+W260Y; o. N33K+F51V+E56K+L69R+K98E+V187D; p. N33K+F51V+E56K+L69R+K98E+E210K; q. N33K+F51V+E56K+L69R+K98E+G225P; r. N33K+F51V+E56K+L69R+K98E+T256P; s. N33K+F51V+E56K+K98E+K163P+E210K; t. N33K+F51V+E56K+K98E+V176L+E210K+Y220F; u. N33K+F51V+D57G+K98I; v. N33K+F51V+L69R+K98E; w. N33K+F51V+L69R+K98E+V176L+E210K+L227G; x. N33K+F51V+L93I+N94R+F95V y. N33K+F51V+K98E; z. N33K+F51V+K98E+E210R+W260Y; aa. N33K+F51V+K98I; bb. N33K+F51V+K98I +H198S+Y220F; cc. N33K+F51V+K98I+Y220F; dd. N33P+F51V; ee. N33P+F51V+D57G+E210K; and ff. N33P+F51V+K98E. 10. The lipase variant of claim 1 , comprising a set of amino acid substitutions corresponding to the following substitutions of SEQ ID NO: 2, selected from the group consisting of: a. F51V; b. F51V+E56K+L69R+K98E; c. F51V+E56K+E87K+K98E; d. F51V+D57G+N101D+E210K; e. F51V+L69R+E87K+K98E; f. F51V+L69R+K98E+E210K; g. F51V+I86P+E87A+G91A+N92D+F95Y+D96T+L97P+K98Q+T252I+T255I; h. F51V+E87K+K98E; i. F51V+K98E+N101D; j. F51V+K98E+E210K; and k. F51V+V176L. 11. The lipase variant of claim 1 , further comprising an alteration at any of positions: 4, 27, 33, 38, 57, 58, 60, 83, 86, 91, 94, 97, 99, 111, 150, 163, 210, 216, 225, 227, 231, 249, 254, 255, 256, 263, 264, 265, 266, 267, and 269 of SEQ ID NO: 2. 12. The lipase variant of claim 1 , wherein the improved stability is stability in detergent compositions, stability in detergent compositions containing protease, stability in the presence of protease, stability under storage conditions, stability under storage conditions in the presence of protease, or thermostability, as compared to the lipase of SEQ ID NO: 2. 13. A detergent composition comprising the lipase variant of claim 1 and a surfactant. 14. A detergent composition comprising the lipase variant of claim 2 and a surfactant. 15. A detergent composition comprising the lipase variant of claim 3 and a surfactant. 16. A detergent composition comprising the lipase variant of claim 4 and a surfactant.
Carboxylic ester hydrolases (3.1.1) · CPC title
containing lipase · CPC title
Triglyceride splitting, e.g. by means of lipase · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.